This list is an analysis based on recent market events. It's not an investment recommendation.
Specializing in pharmaceutical innovation, AcuCort AB (publ) focuses on the development and commercialization of glucocorticoid dexamethasone film products, particularly for acute allergic conditions. Among its offerings is Zeqmelit, a medication with diverse therapeutic uses. Zeqmelit addresses severe and acute allergic reactions, pediatric croup, chemotherapy-induced nausea and vomiting, and also serves as a treatment for COVID-19 patients who require supplemental oxygen. The company, established in 2006, is headquartered in Lund, Sweden.
FAQs
What is AcuCort AB stock price today?▼
The current price of ACUC.ST is SEK0.50 SEK — it has increased by +0.2% in the past 24 hours. Watch AcuCort AB stock price performance more closely on the chart.
What is AcuCort AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange AcuCort AB stocks are traded under the ticker ACUC.ST.
Is AcuCort AB stock price growing?▼
ACUC.ST stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year AcuCort AB has showed a -21.94% decrease.
What is AcuCort AB market cap?▼
Today AcuCort AB has the market capitalization of 116.75M
What is AcuCort AB revenue for the last year?▼
AcuCort AB revenue for the last year amounts to 687,000 SEK.
What is AcuCort AB net income for the last year?▼
ACUC.ST net income for the last year is -26.19M SEK.
How many employees does AcuCort AB have?▼
As of November 2, 2026, the company has 5 employees.
In which sector is AcuCort AB located?▼
AcuCort AB operates in the Health & Wellness sector.
When did AcuCort AB complete a stock split?▼
AcuCort AB has not had any recent stock splits.
Where is AcuCort AB headquartered?▼
AcuCort AB is headquartered in Lund, Sweden.